Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · IEX Real-Time Price · USD
0.903
+0.009 (1.02%)
At close: Mar 27, 2024, 4:00 PM
0.910
+0.007 (0.78%)
Pre-market: Mar 28, 2024, 7:01 AM EDT
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $65.08 million as of March 28, 2024. Its market cap has decreased by -74.95% in one year.
Market Cap
65.08M
Enterprise Value
-117.36M
1-Year Change
-74.95%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $319.30M to $65.08M, a decrease of -79.62%. That is a compound annual growth rate of -24.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 65.10M | -2.25% |
Mar 25, 2024 | 66.60M | -6.20% |
Mar 22, 2024 | 71.00M | 1.00% |
Mar 21, 2024 | 70.30M | 8.32% |
Mar 20, 2024 | 64.90M | 2.37% |
Mar 19, 2024 | 63.40M | 0.16% |
Mar 18, 2024 | 63.30M | -1.25% |
Mar 15, 2024 | 64.10M | 3.55% |
Mar 14, 2024 | 61.90M | -6.50% |
Mar 13, 2024 | 66.20M | -2.07% |
Mar 12, 2024 | 67.60M | -2.45% |
Mar 11, 2024 | 69.30M | -0.43% |
Mar 8, 2024 | 69.60M | -4.26% |
Mar 7, 2024 | 72.70M | -2.94% |
Mar 6, 2024 | 74.90M | - |
Mar 5, 2024 | 74.90M | 1.08% |
Mar 4, 2024 | 74.10M | -1.07% |
Mar 1, 2024 | 74.90M | -1.83% |
Feb 29, 2024 | 76.30M | 0.93% |
Feb 28, 2024 | 75.60M | 7.23% |
Feb 27, 2024 | 70.50M | 8.29% |
Feb 26, 2024 | 65.10M | -0.46% |
Feb 23, 2024 | 65.40M | 5.83% |
Feb 22, 2024 | 61.80M | 1.98% |
Feb 21, 2024 | 60.60M | 0.83% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Landos Biopharma | 67.20M |
Ikena Oncology | 67.08M |
Cidara Therapeutics | 67.06M |
Carmell Therapeutics | 66.94M |
Cryo-Cell International | 66.63M |
Sensus Healthcare | 65.41M |
Eagle Pharmaceuticals | 65.37M |
HCW Biologics | 64.57M |